HepC maintains its corporate headquarters and research and development group in Budapest, Hungary and Rockville, Maryland, USA
HepC Therapeutics Inc. – Superinfection Hungary Business Office:
Tamás Bakács, MBA Miko u. 3. II. em. 11. ,1012 Budapest, HU |
HepC Therapeutics Inc. – Superinfection USA Business Office:
Imre Kovesdi, Ph.D. 7713 Warbler, Rockville, MD, 20855, USA |
For more information on HepC, its product candidates and licensing or partnering opportunities, please also contact: tamas@superinfectiontherapy.com